Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.37 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.37 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.34 |
| ▸ | FDPS | P14324 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7081905 | 1.00 | LMNA (0.48) | LMNACYP3A4ALDH1A1DNM1PRSS1 | |
| SCHEMBL3915871 | 1.00 | LMNA (0.48) | LMNACYP3A4ALDH1A1DNM1PRSS1 | |
| SCHEMBL3313081 | 0.93 | LMNA (0.41) | LMNACYP3A4ALDH1A1DNM1PRSS1 | |
| SCHEMBL1776604 | 0.88 | LMNA (0.54) | LMNACYP3A4ALDH1A1DNM1PRSS1 | |
| SCHEMBL8387794 | 0.88 | LMNA (0.54) | LMNACYP3A4ALDH1A1DNM1PRSS1 | |
| SCHEMBL18327083 | 0.88 | LMNA (0.54) | LMNACYP3A4ALDH1A1DNM1PRSS1 | |
| SCHEMBL20394323 | 0.88 | LMNA (0.54) | LMNACYP3A4ALDH1A1DNM1PRSS1 | |
| SCHEMBL574982 | 0.88 | LMNA (0.54) | LMNACYP3A4ALDH1A1DNM1PRSS1 | |
| SCHEMBL21641724 | 0.88 | LMNA (0.54) | LMNACYP3A4ALDH1A1DNM1PRSS1 | |
| SCHEMBL20253212 | 0.88 | LMNA (0.54) | LMNACYP3A4ALDH1A1DNM1PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1908816-B1 | BASE OIL FOR HYDRAULIC OIL AND HYDRAULIC OIL COMPOSITIONS | NIPPON OIL CORP (JP) | 2015-04-29 | — | — | EP | disclosed |
| US-8735335-B2 | Base oil for hydraulic oil and composition using the same | NIPPON OIL CORPORATION (JP) | 2014-05-27 | — | — | US | disclosed |
| US-20120172268-A1 | BASE OIL FOR HYDRAULIC OIL AND COMPOSITION USING THE SAME | NIPPON OIL CORPORATION (JP) | 2012-07-05 | — | — | US | disclosed |
| US-20100144571-A1 | BASE OIL FOR HYDRAULIC OIL AND COMPOSITION USING THE SAME | NIPPON OIL CORPORATION (JP) | 2010-06-10 | — | — | US | disclosed |
| EP-1908816-A1 | BASE OIL FOR HYDRAULIC OIL AND HYDRAULIC OIL COMPOSITIONS | Nippon Oil Corporation (JP) | 2008-04-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100144571-A1 | BASE OIL FOR HYDRAULIC OIL AND COMPOSITION USING THE SAME | GET3, CPNE4, POLG | LMNA 2160/4885CYP3A4 1936/4885ALDH1A1 4555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.